BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24249678)

  • 1. DNA damage-binding complex recruits HDAC1 to repress Bcl-2 transcription in human ovarian cancer cells.
    Zhao R; Han C; Eisenhauer E; Kroger J; Zhao W; Yu J; Selvendiran K; Liu X; Wani AA; Wang QE
    Mol Cancer Res; 2014 Mar; 12(3):370-80. PubMed ID: 24249678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Damaged DNA-binding protein down-regulates epigenetic mark H3K56Ac through histone deacetylase 1 and 2.
    Zhu Q; Battu A; Ray A; Wani G; Qian J; He J; Wang QE; Wani AA
    Mutat Res; 2015 Jun; 776():16-23. PubMed ID: 26255936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
    Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
    Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of DDB2 enhances the sensitivity of human ovarian cancer cells to cisplatin by augmenting cellular apoptosis.
    Barakat BM; Wang QE; Han C; Milum K; Yin DT; Zhao Q; Wani G; Arafa el-SA; El-Mahdy MA; Wani AA
    Int J Cancer; 2010 Aug; 127(4):977-88. PubMed ID: 20013802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Basal transcriptional regulation of human damage-specific DNA-binding protein genes DDB1 and DDB2 by Sp1, E2F, N-myc and NF1 elements.
    Nichols AF; Itoh T; Zolezzi F; Hutsell S; Linn S
    Nucleic Acids Res; 2003 Jan; 31(2):562-9. PubMed ID: 12527763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
    Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
    J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cullin 4B-based UV-damaged DNA-binding protein ligase binds to UV-damaged chromatin and ubiquitinates histone H2A.
    Guerrero-Santoro J; Kapetanaki MG; Hsieh CL; Gorbachinsky I; Levine AS; Rapić-Otrin V
    Cancer Res; 2008 Jul; 68(13):5014-22. PubMed ID: 18593899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CtBP1-HDAC1/2-IRF1 transcriptional complex represses the expression of the long noncoding RNA GAS5 in human osteosarcoma cells.
    Zhang X; Du K; Lou Z; Ding K; Zhang F; Zhu J; Chang Z
    Int J Biol Sci; 2019; 15(7):1460-1471. PubMed ID: 31337976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DDB1-CUL4ADDB2 ubiquitin ligase is deficient in xeroderma pigmentosum group E and targets histone H2A at UV-damaged DNA sites.
    Kapetanaki MG; Guerrero-Santoro J; Bisi DC; Hsieh CL; Rapić-Otrin V; Levine AS
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2588-93. PubMed ID: 16473935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDB2 represses ovarian cancer cell dedifferentiation by suppressing ALDH1A1.
    Cui T; Srivastava AK; Han C; Wu D; Wani N; Liu L; Gao Z; Qu M; Zou N; Zhang X; Yi P; Yu J; Bell EH; Yang SM; Maloney DJ; Zheng Y; Wani AA; Wang QE
    Cell Death Dis; 2018 May; 9(5):561. PubMed ID: 29752431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage binding protein component DDB1 participates in nucleotide excision repair through DDB2 DNA-binding and cullin 4A ubiquitin ligase activity.
    Li J; Wang QE; Zhu Q; El-Mahdy MA; Wani G; Praetorius-Ibba M; Wani AA
    Cancer Res; 2006 Sep; 66(17):8590-7. PubMed ID: 16951172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1.
    Yuan Z; Cao K; Lin C; Li L; Liu HY; Zhao XY; Liu L; Deng HX; Li J; Nie CL; Wei YQ
    Mol Med; 2011; 17(11-12):1262-74. PubMed ID: 21863213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic repression of LEDGF during UVB exposure by recruitment of SUV39H1 and HDAC1 to the Sp1-responsive elements within LEDGF promoter CpG island.
    Bhargavan B; Chhunchha B; Fatma N; Kubo E; Kumar A; Singh DP
    Epigenetics; 2013 Mar; 8(3):268-80. PubMed ID: 23386123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.
    Duan H; Heckman CA; Boxer LM
    Mol Cell Biol; 2005 Mar; 25(5):1608-19. PubMed ID: 15713621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor suppressor protein p53 recruits human Sin3B/HDAC1 complex for down-regulation of its target promoters in response to genotoxic stress.
    Bansal N; Kadamb R; Mittal S; Vig L; Sharma R; Dwarakanath BS; Saluja D
    PLoS One; 2011; 6(10):e26156. PubMed ID: 22028823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription Repressor Protein ZBTB25 Associates with HDAC1-Sin3a Complex in Mycobacterium tuberculosis-Infected Macrophages, and Its Inhibition Clears Pathogen by Autophagy.
    Madhavan A; Arun KB; Pushparajan AR; Balaji M; Kumar RA
    mSphere; 2021 Feb; 6(1):. PubMed ID: 33627504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The zinc finger repressor, ZBP-89, recruits histone deacetylase 1 to repress vimentin gene expression.
    Wu Y; Zhang X; Salmon M; Zehner ZE
    Genes Cells; 2007 Aug; 12(8):905-18. PubMed ID: 17663720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DDB2 suppresses tumorigenicity by limiting the cancer stem cell population in ovarian cancer.
    Han C; Zhao R; Liu X; Srivastava A; Gong L; Mao H; Qu M; Zhao W; Yu J; Wang QE
    Mol Cancer Res; 2014 May; 12(5):784-94. PubMed ID: 24574518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.